| Alterations in myocardial uptake of glutamate and release of alanine after propranolol, nifedipine, and glyceryl trinitrate in coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 2581096 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We examined the effects of antianginal drugs on myocardial uptake of glutamate and release of alanine in patients with chronic effort angina. Thirty-three patients underwent two periods of atrial pacing, the second preceded either by no medication (controls) (n = 8), 0.1 mg/kg i.v. propranolol (n = 8), 30 mg nifedipine sublingually (n = 9) or 0.75 mg glyceryl trinitrate sublingually (n = 8). Before, during, and after each pacing period, coronary sinus blood flow (CSBF), oxygen uptake, and arteriocoronary sinus differences (ACs) of plasma glutamate and alanine were determined. In all groups of patients, arterial alanine concentration fell during the second test. Except for this fall, no metabolic change was seen in controls. Propranolol increased circulating arterial concentration and ACs values of glutamate throughout the test. Nifedipine did not change arterial glutamate concentration but decreased ACs glutamate before and after pacing. Glyceryl trinitrate decreased CSBF, oxygen uptake, and net myocardial uptake of glutamate before pacing despite unchanged arterial level and ACs values. Alterations of myocardial glutamate uptake after drugs may reflect metabolic effects of propranolol primarily exerted on extracardial sites and of nifedipine exerted on the myocardium itself, whereas changes after glyceryl trinitrate seem to be secondary to its cardiac unloading effect. Alterations in myocardial release of alanine were too small and inconsistent to be taken as drug effects. |
| | |
Authors:
|
A Thomassen; T T Nielsen; J P Bagger |
Related Documents
:
|
12691286 - Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in ... 2945626 - Failure of propranolol to prevent chronic hyperthyroid induced cardiac hypertrophy and ... 1277706 - Effect of lidocaine on right ventricular muscle refractoriness. 6981016 - Myocardial protection by lidocaine hydrochloride in aorto-coronary bypass surgery. 18250366 - Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ische... 12189296 - Cardiac chaos: implications for congestive heart failure. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 7 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 1985 Mar-Apr |
Date Detail:
|
Created Date: 1985-06-18 Completed Date: 1985-06-18 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 394-400 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Alanine / secretion Blood Pressure / drug effects Coronary Disease / metabolism* Female Glutamates / metabolism Glutamic Acid Heart Rate / drug effects Humans Male Middle Aged Myocardium / metabolism* Nifedipine / pharmacology* Nitroglycerin / pharmacology* Propranolol / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Glutamates; 21829-25-4/Nifedipine; 525-66-6/Propranolol; 55-63-0/Nitroglycerin; 56-41-7/Alanine; 56-86-0/Glutamic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Disopyramide and quinidine bind with inverse selectivity to muscarinic receptors in cardiac and extr...
Next Document: Alpha 1- and alpha 2-adrenoceptor-mediated pressor responses: are they differentiated by calcium ant...